Filing Details
- Accession Number:
- 0001140361-12-050627
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-11 18:59:50
- Reporting Period:
- 2012-12-07
- Filing Date:
- 2012-12-11
- Accepted Time:
- 2012-12-11 18:59:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-07 | 3,000 | $9.86 | 170,691 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-07 | 3,000 | $47.04 | 167,691 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-10 | 3,000 | $12.99 | 170,691 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-10 | 3,000 | $48.03 | 167,691 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2012-12-07 | 3,000 | $0.00 | 3,000 | $9.86 |
| Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2012-12-10 | 3,000 | $0.00 | 3,000 | $12.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,241,764 | 2006-05-11 | 2015-11-10 | No | 4 | M | Direct |
| 2,238,764 | 2006-11-11 | 2016-05-10 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 12, 2012.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $46.66 to $47.99. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 10, 2012.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $47.15 to $48.26. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vests 1/3 each on May 11, 2006, May 11, 2007, May 11, 2008.
- Original option grant vests 6/48th on November 11, 2006 and 1/48th on the 11th day of every month thereafter.
Billionaire Hedge Funds
